Ignite Creation Date:
2025-12-24 @ 10:17 PM
Ignite Modification Date:
2025-12-25 @ 7:51 PM
Study NCT ID:
NCT05184335
Status:
RECRUITING
Last Update Posted:
2024-12-19
First Post:
2021-11-29
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Safety and Efficacy of Brilaroxazine (RP5063) in Schizophrenia
Sponsor:
Reviva Pharmaceuticals
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-01-24
Start Date Type:
ACTUAL
Primary Completion Date:
2025-02
Primary Completion Date Type:
ESTIMATED
Completion Date:
2025-02
Completion Date Type:
ESTIMATED
First Submit Date:
2021-11-29
First Submit QC Date:
None
Study First Post Date:
2022-01-11
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-12-16
Last Update Post Date:
2024-12-19
Last Update Post Date Type:
ACTUAL